Encore Medical sets firm $5 IPO price for its NYSE American debut
As seen on the 24/7 Wall St. homepage on September 28, 2026.
Encore Medical sets $5 fixed price for $15 million NYSE American IPO
Encore Medical locked its IPO at a fixed $5 a share for 3 million shares, a $15 million raise on NYSE American. This is the eighth amendment to the S-1, and a firm price with no range usually means pricing is close.
Continue ReadingShow less
Encore Medical's eighth S-1 amendment locks the IPO at a fixed price of $5 per share, the clearest sign yet that the deal is about to price.
The offering covers 3 million shares, a small-cap debut targeting NYSE American, the exchange that caters to earlier-stage and smaller companies than the main NYSE board.
Eight amendments reflect repeated rounds of SEC review, and reaching this stage with a locked price suggests those conversations are largely resolved.
For investors watching the small-cap IPO calendar, the window between this amendment and an expected pricing announcement is typically short.
Mentioned: EMI